RxDoctor Payments DataLook up a doctor →

Krystal Shilo

Gerontology · Houston, TXNPI 1477222107

Payments from drug & device makers

$8,412in general payments, 2019–2025

Across 371 payments — averaging $22.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$623
  • Pfizer$548
  • AbbVie$458
  • Tempus AI, Inc$438
  • Jazz Pharmaceuticals Inc.$386
  • Novartis$373
  • plus $6K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson(2 entities)26$623
Pfizer29$548
AbbVie13$458
Tempus AI, Inc25$438
Jazz Pharmaceuticals Inc.7$386
Novartis18$373
Astellas Pharma US Inc13$353
E.r. Squibb & Sons, L.L.C.21$351
Bristol Myers Squibb14$335
Seagen Inc.8$329
AstraZeneca(2 entities)15$324
Daiichi Sankyo Inc.14$303
Bayer7$224
Merck10$222
Sanofi10$210
Array Biopharma Inc8$173
Tersera Therapeutics LLC7$173
Rigel Pharmaceuticals, Inc.8$171
Beone Medicines USA, Inc.6$163
Lilly USA, LLC7$153
Eisai Inc.6$126
Pharmaessentia USA Corporation6$123
Sobi, Inc5$99
Pharmacosmos Therapeutics Inc.4$88
Tactile Systems Technology Inc5$82
Fennec Pharmaceuticals, Inc.6$80
EMD Serono, Inc.4$79
Deciphera Pharmaceuticals Inc.3$78
GSK3$73
Amgen3$69
Ipsen Biopharmaceuticals, Inc3$69
Springworks Therapeutics, Inc.3$69
Taiho Oncology, Inc.3$67
Incyte Corporation4$64
Morphosys, US Inc.3$59
AVEO Pharmaceuticals, Inc.3$57
Mirati Therapeutics, Inc.3$56
Pharmacyclics LLC, An Abbvie Company2$51
Blueprint Medicines Corporation2$50
Stemline Therapeutics Inc.2$45
Regeneron Healthcare Solutions, Inc.2$44
Servier Pharmaceuticals LLC2$42
Legend Biotech USA Inc.2$40
Puma Biotechnology, Inc.2$38
Kyowa Kirin, Inc.2$36
Genentech USA, Inc.2$33
Adaptive Biotechnologies Corporation2$32
Iovance Biotherapeutics, Inc.1$31
Beigene USA, Inc.1$28
Invivyd Inc1$25
Apellis Pharmaceuticals, Inc.1$23
Geron Corporation1$22
Dendreon Pharmaceuticals LLC1$21
Sumitomo Pharma America, Inc.1$21
Tolmar Pharmaceuticals, Inc.1$20
CTI Biopharma Corp.1$20
Genmab U.S., Inc.1$19
ADC Therapeutics America, Inc.1$18
Caris MPI, Inc.1$16
Gilead1$16

How this compares

$8,412 in reported general payments places this provider in the 95th percentile of 653 gerontology providers in Texas.

See all gerontology providers in Texas →

Medicare billing

Part B allowed, 2024
$53,199
Medicare patients
197
Services billed
1,223

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gerontology in Houston

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →